drugset / Trial / NCT06022354
To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 1, randomized, double-blind, placebo-controlled trial of SIM0278 in healthy subjects. The study will be conducted in 2 parts. Part 1 is single ascending dose study. Part 2 is multiple ascending dose study.
Timeline
- Start
- 2023-08-23
- Primary completion
- 2025-03-18
- Completion
- 2025-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SIM0278 | Unknown | — | Subcutaneous |
Indications
No indication recorded.